close
Translating an in vitro cellular system into a relevant clinical read-out requires a fully functional cell model.
Ncardia iPSC-derived cell models are used routinely in safety pharmacology, drug efficacy testing and cell therapy applications. These models are also utilized in Ncardia Services.
Human iPSC-derived cardiomyocytes produced without genetic modifications and cultured in a defined, serum-free medium for drug discovery.
Analyzing drug effects in hiPSC-derived cardiomyocytes is easier with this ready-to-use Maestro plate containing Ncyte Cardiomyocytes.
Cryopreserved hiPSC-derived astrocytes for neuronal co-cultures and applicable for neuro-inflammatory studies.
Ncardia manufactures select cell models as dedicated batches for individual clients. This service provides the opportunity to customize critical cell model parameters to your drug discovery and cell therapy applications. Cell models can be assayed at Ncardia before delivery to qualify performance in your specific application. Quantities and fill formats are made to order as part of the service. The manufacturing process can be applied to an Ncardia iPSC line or your iPSC line. In addition to the cell models listed below, protocols for the catalog products above can be performed with any iPSC line as a service.
Human iPS-derived atrial cardiomyoctes for safety, disease modeling, drug screening, and cell therapy.
Human iPS-derived Cardiomyoctes for safety, disease modeling, drug screening, and cell therapy.
Human iPS-derived vascular endothelial cells for vascular disease modeling, drug screening, and vascular tissue engineering.
